Raymond James Financial Inc. Raises Stock Holdings in Integer Holdings Corporation $ITGR

Key Points

• Raymond James Financial Inc. increased its stake in Integer Holdings Corporation by 6.9%, owning approximately $36.25 million worth of shares after purchasing an additional 19,839 shares in the first quarter.
• Integer's stock price is showing positive momentum, up 3.6%, with a 52-week high of $146.36 and a current trading price of $110.65.
• Several hedge funds have recently modified their positions in Integer, with 99.29% of the stock now owned by institutional investors, indicating strong institutional interest in the company.

Raymond James Financial Inc. lifted its stake in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 6.9% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 307,141 shares of the medical equipment provider's stock after acquiring an additional 19,839 shares during the period. Raymond James Financial Inc. owned 0.88% of Integer worth $36,245,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. TD Private Client Wealth LLC lifted its holdings in shares of Integer by 5.8% in the first quarter. TD Private Client Wealth LLC now owns 1,524 shares of the medical equipment provider's stock worth $180,000 after buying an additional 83 shares in the last quarter. Xponance Inc. lifted its holdings in shares of Integer by 5.1% in the first quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider's stock worth $297,000 after buying an additional 122 shares in the last quarter. Bessemer Group Inc. lifted its holdings in shares of Integer by 73.1% in the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after buying an additional 125 shares in the last quarter. Emerald Mutual Fund Advisers Trust lifted its holdings in shares of Integer by 0.8% in the fourth quarter. Emerald Mutual Fund Advisers Trust now owns 19,867 shares of the medical equipment provider's stock worth $2,633,000 after buying an additional 152 shares in the last quarter. Finally, Nisa Investment Advisors LLC lifted its holdings in shares of Integer by 1.0% in the first quarter. Nisa Investment Advisors LLC now owns 20,450 shares of the medical equipment provider's stock worth $2,413,000 after buying an additional 197 shares in the last quarter. Institutional investors own 99.29% of the company's stock.

Integer Price Performance

Shares of ITGR stock traded up $0.20 during trading hours on Friday, hitting $107.58. 166,088 shares of the company's stock were exchanged, compared to its average volume of 282,262. The company has a market capitalization of $3.77 billion, a PE ratio of 47.39, a PEG ratio of 0.85 and a beta of 1.02. Integer Holdings Corporation has a 12-month low of $104.93 and a 12-month high of $146.36. The business's 50 day simple moving average is $112.71 and its 200-day simple moving average is $118.09. The company has a current ratio of 3.41, a quick ratio of 2.18 and a debt-to-equity ratio of 0.72.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.02). The business had revenue of $476.00 million for the quarter, compared to analysts' expectations of $464.37 million. Integer had a return on equity of 12.27% and a net margin of 4.61%.The company's revenue was up 11.4% compared to the same quarter last year. During the same period last year, the business posted $1.30 earnings per share. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, equities research analysts anticipate that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Insider Activity at Integer

In other Integer news, Director Donald J. Spence sold 14,739 shares of Integer stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the transaction, the director directly owned 18,781 shares of the company's stock, valued at approximately $2,260,856.78. This trade represents a 43.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of Integer stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the transaction, the director directly owned 22,170 shares in the company, valued at $2,672,815.20. This trade represents a 28.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.16% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Truist Financial lowered their price target on shares of Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a report on Friday, July 25th. Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and increased their price target for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Raymond James Financial lowered their target price on shares of Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a research note on Friday, July 25th. Wall Street Zen raised shares of Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. Finally, Wells Fargo & Company lowered their target price on shares of Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $140.25.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.